文献速递糖尿病

睡眠优化干预对1型糖尿病成人血糖目标的影响:随机对照试验

Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial.
PubMed 文献 · Diabetes Care · 2026-01-01

本研究将睡眠时长不足或睡眠不规律的1型糖尿病成人随机分为睡眠优化组(n=73)和健康生活对照组(n=71),进行12周远程干预。12周时两组A1C和CGM参数无显著差异,但睡眠优化组在6周时糖尿病痛苦和主观睡眠质量改善,且基线A1C≥7%者12周时A1C降幅更大。

要点

  • 睡眠优化干预未显著改善整体血糖目标或客观睡眠参数。
  • 基线A1C≥7%者接受睡眠优化后12周A1C降幅更大(边际均值-0.32%)。
  • 6周时睡眠优化组糖尿病痛苦和主观睡眠质量改善,但其他时点未持续。

核心结论

  • 睡眠优化干预未改善整体血糖目标或睡眠参数,但基线A1C欠佳者可能获益。

研究设计与样本

  • 随机对照平行干预试验,纳入睡眠短(<6.5 h/晚)或不规律(睡眠时长变异性≥1 h)的1型糖尿病成人,睡眠优化组n=73,健康生活对照组n=71,远程8次会话12周。

主要发现

  • 12周时两组A1C和CGM参数无显著差异。
  • 6周时睡眠优化组较对照组糖尿病痛苦降低(中位差-0.18,95%CI -0.35至-0.01)且主观睡眠质量改善(-0.96,95%CI -0.17至-0.23),其他时点无差异。

临床怎么用

  • 对A1C控制欠佳的1型糖尿病成人,睡眠优化可能作为辅助策略改善血糖。

局限性

  • 整体血糖目标未改善,睡眠参数组间无显著差异,部分获益仅见于特定亚组和时点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effects of a sleep intervention (Sleep-Opt) compared with an attention control intervention (Healthy Living) on glycemic targets and psychological outcomes in adults with type 1diabetes (T1D). RESEARCH DESIGN AND METHODS: Adults with T1D and short (<6.5 h/night) or irregular (variability of sleep duration ≥1 h) sleep were randomly assigned to either the Sleep-Opt (n = 73) or Healthy Living control (n = 71) intervention, both of which were remotely delivered in eight sessions for 12 weeks. Primary (A1C, continuous glucose monitoring [CGM], and objective sleep) and secondary (psychological and subjective sleep) outcomes were collected at baseline and 6, 12, and 24 weeks, with 12 weeks being a primary end point. RESULTS: A1C and CGM parameters at 12 weeks indicated no significant differences between groups. Sleep duration increased at 6 weeks in both groups, but no significant differences were observed between groups at any time point. Sleep-Opt participants had reduced diabetes distress (median difference -0.18 [95% CI -0.35, -0.01]) and improved subjective sleep quality (-0.96 [-0.17, -0.23]) compared with the Healthy Living group at 6 weeks but not at other time points. A significant interaction was found suggesting the effect of the intervention depended on baseline A1C level. At 12 weeks, the Sleep-Opt group with baseline A1C ≥7% had a lower A1C level than the Healthy Living group (marginal mean -0.32% [95% CI -0,64%, -0.005%]; -3.5 [95% CI -7.0, -0.1] mmol/mol; P = 0.047). CONCLUSIONS: Sleep-Opt did not improve glycemic targets or sleep parameters, although sleep improved in both intervention groups. Glycemic benefits were observed in participants with suboptimal A1C, suggesting a possible role of sleep intervention in this patient group.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Martyn-Nemeth P, Duffecy J, Steffen AD, et al. Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial. Diabetes Care. 2026. PMID: 42149583. doi:10.2337/dc26-0273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。